Article Details

Artiva Biotherapeutics Announces FDA Allowance of IND for AB-201, a HER2-Targeted CAR ...

Retrieved on: 2022-09-21 07:53:35

Tags for this article:

Click the tags to see associated articles and topics

Artiva Biotherapeutics Announces FDA Allowance of IND for AB-201, a HER2-Targeted CAR .... View article details on HISWAI: https://pipelinereview.com/index.php/2022092181655/DNA-RNA-and-Cells/Artiva-Biotherapeutics-Announces-FDA-Allowance-of-IND-for-AB-201-a-HER2-Targeted-CAR-NK-for-the-Treatment-of-Solid-Tumors.html

Excerpt

... and multiple HER2-directed agents, including monoclonal antibodies, antibody-drug conjugates, and small molecule tyrosine kinase inhibitors ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up